XML 77 R62.htm IDEA: XBRL DOCUMENT v3.23.3
Business Combinations - Purchase Consideration (Details)
$ in Thousands, € in Millions
12 Months Ended
Feb. 02, 2023
USD ($)
Oct. 03, 2022
USD ($)
Jul. 01, 2022
USD ($)
Apr. 02, 2021
USD ($)
Dec. 03, 2020
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2021
USD ($)
Jun. 30, 2023
USD ($)
Dec. 31, 2022
USD ($)
Oct. 03, 2022
EUR (€)
Business Acquisition [Line Items]                      
Aggregate purchase price, net of cash acquired           $ 386,508 $ 125,876 $ 93,712      
Short-term restricted cash           4,650 382,596 $ 7,145      
Contingent consideration liability           $ 0     $ 0 $ 18,500  
Ziath Ltd and Subsidiaries                      
Business Acquisition [Line Items]                      
Aggregate purchase price, net of cash acquired $ 16,000                    
B Medical Systems S.a.r.l and Subsidiaries                      
Business Acquisition [Line Items]                      
Total purchase price   $ 432,200                  
Contingent consideration   17,000                  
Aggregate purchase price, net of cash acquired   $ 424,000                  
Additional contingent consideration | €                     € 50.0
Prepaid assets             43,100        
Short-term restricted cash             $ 381,000        
Contingent consideration liability, achievement of certain revenue targets, term   1 year                  
Contingent consideration liability                 $ 0 $ 18,500  
Barkey Holding GmbH and Subsidiaries                      
Business Acquisition [Line Items]                      
Total purchase price     $ 84,800                
Abeyatech LLC                      
Business Acquisition [Line Items]                      
Total purchase price       $ 9,900              
Contingent consideration liability       $ 9,400              
Trans-Hit Biomarkers                      
Business Acquisition [Line Items]                      
Total purchase price         $ 15,100